← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vxbiosciences, Inc.
Oakland, CA
$5,117,583
Total funding
2
Grants
Funding over time
peak $2.8M · FY2021–23$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
Funding mix
By agency
NIH$5,117,583 · 2
By mechanism
R01$4,817,583 · 1
R42$300,000 · 1
Investigators at Vxbiosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention$2,820,494
R01 · FY2021 · AI
Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention$1,997,089
R01 · FY2023 · AI
Development of a first-in-class antiviral to address CMV drug resistance in immunocompromised patients$300,000
R42 · FY2023 · AI